找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affect; Proceedings of the T Joel Morganroth,

[復(fù)制鏈接]
樓主: CLIP
31#
發(fā)表于 2025-3-27 00:49:39 | 只看該作者
32#
發(fā)表于 2025-3-27 03:13:02 | 只看該作者
33#
發(fā)表于 2025-3-27 06:19:24 | 只看該作者
What Should be Required for FDA Approvability of a New Antihypertensive Drug? What is the FDA’s Viewe fairly clear. Antihypertensive drugs are approved on the basis of a demonstrated ability to lower blood pressure to a reasonable degree and a reasonably complete characterization of a drug’s pharmacokinetic and pharmacodynamic properties, with particular emphasis on dose-response and on patient ch
34#
發(fā)表于 2025-3-27 12:24:55 | 只看該作者
35#
發(fā)表于 2025-3-27 15:36:50 | 只看該作者
36#
發(fā)表于 2025-3-27 20:24:27 | 只看該作者
37#
發(fā)表于 2025-3-27 21:56:05 | 只看該作者
0166-9842 al and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering
38#
發(fā)表于 2025-3-28 03:02:29 | 只看該作者
39#
發(fā)表于 2025-3-28 06:40:30 | 只看該作者
What Should be Required for FDA Approvability of a New Antihypertensive Drug? What is the FDA’s Viewaracteristics that can alter this response. We have not, up to now, sought evidence of diminished end-organ damage or mortality for each new agent, relying instead on the past studies that showed such benefits of lowering blood pressure.
40#
發(fā)表于 2025-3-28 13:46:51 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 04:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
繁昌县| 花莲市| 如皋市| 长沙县| 泗洪县| 淮南市| 内黄县| 孟津县| 澄城县| 饶阳县| 商洛市| 阳山县| 财经| 安塞县| 油尖旺区| 尤溪县| 福建省| 太仆寺旗| 土默特左旗| 颍上县| 瓦房店市| 瑞金市| 行唐县| 镇坪县| 阜康市| 沂源县| 丹凤县| 高淳县| 鄂伦春自治旗| 深水埗区| 封开县| 金平| 新平| 巍山| 宣恩县| 万全县| 荔波县| 金坛市| 保靖县| 全州县| 友谊县|